Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Source link
Eli Lilly’s weight-loss pill didn’t work so well, and the stock is plunging

Lilly’s stock was tumbling as disappointing trial data for an oral weight-loss pill offset an upbeat earnings report and outlook.
Source link